Document is current
Any future updates will be listed below
-
Authors
Parkes, Eileen E. https://orcid.org/0000-0002-7855-3698
Humphries, Matthew P.
Gilmore, Elaine
Sidi, Fatima A. https://orcid.org/0000-0003-0205-4486
Bingham, Victoria
Phyu, Su M.
Craig, Stephanie
Graham, Catherine
Miller, Joseph
Griffin, Daryl https://orcid.org/0000-0003-2444-9497
Salto-Tellez, Manuel
Madden, Stephen F.
Kennedy, Richard D. https://orcid.org/0000-0003-4737-6163
Bakhoum, Samuel F.
McQuaid, Stephen
Buckley, Niamh E. https://orcid.org/0000-0001-9326-8513
-
Funding
Funding for this research was provided by:
Breast Cancer Now (2012MaySF122)
Cancer Research UK (C11512/A20256, C11512/A20256, C11512/A20256)
- License Information
-
More Information
Article History
Received: 7 October 2020
Accepted: 27 May 2021
First Online: 25 June 2021
Competing interests
: E.E.P. and R.D.K. hold associated patents on file, “Molecular Diagnostic Test for Cancer” and “Gene Signature for Immune Therapies in Cancer”. E.E.P. has served as a consultant for Boehringer Ingleheim. M.S.T. has recently received honoraria for advisory work in relation to the following companies: Incyte, QuanPathDerivatives and M.S.D. He is part of academia-industry consortia supported by the UK government (Innovate UK). These are all unrelated to this work. The remaining authors declare no competing interests.
